Valuation: Treace Medical Concepts, Inc.

Market Cap 287M 251M 232M 213M 403M 27.69B 410M 2.77B 1.09B 13.52B 1.08B 1.06B 46.69B P/E 2026 *
-4.92x
P/E 2027 * -5.3x
Enterprise Value 332M 291M 269M 247M 467M 32.03B 475M 3.2B 1.26B 15.64B 1.25B 1.22B 54.01B EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.69x
Free-Float
74.37%
Yield 2026 *
-
Yield 2027 * -
1 day+0.68%
1 week-4.94%
Current month+11.31%
1 month+7.52%
3 months+136.90%
6 months+67.80%
Current year+80.82%
1 week 4.15
Extreme 4.15
4.75
1 month 3.84
Extreme 3.84
4.78
Current year 1.17
Extreme 1.17
4.78
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
24.78
5 years 1.17
Extreme 1.17
31.76
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Compliance Officer 50 2022-09-30
Director TitleAgeSince
Director/Board Member 68 2020-11-19
Chairman 80 2014-06-30
Director/Board Member 65 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
6/11/26 Buy

Chief Executive Officer

9,891 0.0152%
6/10/26 Other

Chief Executive Officer

0 0%
6/1/26 Buy

Chief Executive Officer

50,000 0.0771%
Change 5-day change 1-year change 3-year change Capi.($)
+0.68%-4.94%-24.27%-82.19% 287M
+0.91%+0.52%+36.34%+1.48% 12.57B
+2.18%+3.84%+13.10%+14.08% 5.96B
+2.42%-0.56%+54.21%+29.08% 5.66B
-1.41%+6.41%-28.11%+19.24% 4.38B
+2.98%+5.51% - - 4.46B
+1.35%+8.96%-20.34%-21.58% 4.1B
+2.43%-5.03%-1.02%-58.89% 1.9B
+0.79%-1.40%-0.63%+248.14% 1.87B
-0.98%-0.33%+56.31%-4.13% 1.56B
Average +1.14%+0.21%+9.51%+16.14% 4.28B
Weighted average by Cap. +1.30%+1.12%+18.63%+15.25%

Financials

2026 *2027 *
Net sales 206M 180M 167M 153M 290M 19.88B 295M 1.99B 781M 9.71B 775M 758M 33.51B 222M 194M 179M 165M 311M 21.37B 317M 2.14B 840M 10.44B 833M 815M 36.03B
Net income -58.31M -50.96M -47.13M -43.25M -81.86M -5.62B -83.28M -562M -221M -2.74B -219M -214M -9.47B -54.66M -47.78M -44.18M -40.55M -76.74M -5.27B -78.07M -527M -207M -2.57B -205M -201M -8.88B
Net Debt 45.05M 39.38M 36.42M 33.42M 63.25M 4.34B 64.35M 434M 171M 2.12B 169M 165M 7.32B 88.04M 76.96M 71.17M 65.31M 124M 8.48B 126M 849M 333M 4.14B 331M 323M 14.3B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-07-16 US$4.430 +0.68% 412,796
26-07-15 US$4.400 -0.90% 344,736
26-07-14 US$4.440 -3.06% 560,918
26-07-13 US$4.580 +6.02% 711,461
26-07-10 US$4.320 -7.30% 431,318
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.430USD
Average target price
4.667USD
Spread / Average Target
+5.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock